DecisionDx-Melanoma Survey Reveals Patient Care Insights Among NPs and PAs dermatologytimes.com/view/decisiond… via dermRounds Times

Common Adverse Effects Seen With BRAF/MEK Inhibitor Therapy in Patients With BRAF-Mutated Metastatic Melanoma onclive.com/view/common-ad… via OncLive.com

Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans fredhutch.org/en/news/center…

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025 barrons.com/news/moderna-c…

Immunotherapy Combos Work Differently in Advanced Melanoma insideprecisionmedicine.com/news-and-featu… via @clinicalomics

Chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors bit.ly/3GTKkJs

Rare immune cell holds key to predicting melanoma treatment success news-medical.net/news/20240103/…

DermTech’s cancer test has 99% accuracy in ruling out melanoma clinicaltrialsarena.com/news/dermtechs… via Clinical Trials Arena

🎙️ New on AIM's podcast! Tune in to our first episode of 2024 where we discuss the vital importance of maintaining vitality for all cancer survivors. Don't miss this insightful and empowering conversation. Listen now! #podcast #cancersurvivors #empowerment aimatmelanoma.org/vitality-cance…

Study reveals surprising power of CD4+ T cells against melanoma news-medical.net/news/20240122/…

Exciting News! Join us for a special interview with Melissa Wilson, PA-C, MPAS, and Krista Rubin, MS, FNP-BC, as they discuss the latest advancements in treating advanced nonmelanoma skin cancers. Don't miss out on this educational opportunity. REGISTER: bit.ly/3Sxfw7Z

Imaging after one week on pembrolizumab may predict treatment response in advanced melanoma medicalxpress.com/news/2024-01-i… via Medical Xpress

In patients with resected, high-risk melanoma, the addition of a personalized mRNA-based neoantigen therapy to adjuvant pembrolizumab was more effective than pembrolizumab alone. nature.com/articles/d4159…

TONIGHT: A special edition of From the Clinic to the Living Room w/ Melissa Wilson, PA-C, MPAS, introducing Krista Rubin, MS, FNP-BC, & AIM at Skin Cancer's Ask a Nurse & host of her new webinar series, "Skin Cancer & YOU," premiering Feb. 28th. Register bit.ly/3Sxfw7Z

The Food and Drug Administration approval provides another option for advanced, refractory melanoma aimatmelanoma.org/iovance-biothe…

This Wednesday, we dive deep into the profound impact of a multidisciplinary approach to cancer care. Learn how collaboration between medical professionals leads to more effective treatments and compassionate patient care. REGISTER: bit.ly/48yxbRo

Customizable information packets on #melanoma therapies you can print for your patients. Printable action plan pages, explanatory text, and instructions for customization. #oncologynurse goo.gl/95PCWP

Weber Shares High Hopes for Pembrolizumab/Epacadostat Combo in Melanoma targetedonc.com/news/weber-sha… via Targeted Oncology

Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in #melanoma goo.gl/j9BiVF

An alphabetical list of side effects associated with #immunotherapies used to treat #melanoma. From abdominal bloating to yellowing of skin or eyes, when you select a side effect, you will be taken through key nursing assessments. goo.gl/f3JDjA #oncologynurse